Back
KalVista Pharmaceuticals Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
48
KALV
KalVista Pharmaceuticals
Last Price:
10.21
Seasonality Move:
3.67%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing selling pressure, which indicates risk of future bearish movement.
KalVista Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.14 | Sell |
| 20-day SMA: | 11.51 | Sell |
| 50-day SMA: | 11.33 | Sell |
| 200-day SMA: | 12.34 | Sell |
| 8-day EMA: | 10.99 | Sell |
| 20-day EMA: | 11.26 | Sell |
| 50-day EMA: | 11.54 | Sell |
| 200-day EMA: | 11.78 | Sell |
KalVista Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 40.61 | Sell |
| Chaikin Money Flow: | -296427 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.91 - 12.13) | Sell |
| Bollinger Bands (100): | (10.9 - 13.5) | Sell |
KalVista Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for KalVista Pharmaceuticals Stock
Is KalVista Pharmaceuticals Stock a Buy?
- KalVista Pharmaceuticals share price is 10.45 while KALV 8-day simple moving average is 11.14, which is a Sell signal.
- The stock price of KALV is 10.45 while KalVista Pharmaceuticals 20-day SMA is 11.51, which makes it a Sell.
- KalVista Pharmaceuticals 50-day simple moving average is 11.33 while KALV share price is 10.45, making it a Sell technically.
- KALV stock price is 10.45 and KalVista Pharmaceuticals 200-day simple moving average is 12.34, creating a Sell signal.
KALV Technical Analysis vs Fundamental Analysis
Sell
48
KalVista Pharmaceuticals (KALV)
is a Sell
Is KalVista Pharmaceuticals a Buy or a Sell?
-
KalVista Pharmaceuticals stock is rated a Sell
The current KalVista Pharmaceuticals [KALV] share price is $10.45. The Score for KALV is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
KalVista Pharmaceuticals Stock Info
Market Cap:
514.3M
Price in USD:
10.45
Share Volume:
314.04K
KalVista Pharmaceuticals 52-Week Range
52-Week High:
16.88
52-Week Low:
7.39
Sell
48
KalVista Pharmaceuticals (KALV)
is a Sell
KalVista Pharmaceuticals Share Price Forecast
-
What is the KalVista Pharmaceuticals stock price today?
The KalVista Pharmaceuticals stock price is 10.45 USD today. -
Will KALV stock go up or go down?
KalVista Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is KalVista Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, KalVista Pharmaceuticals is overvalued.
Is KalVista Pharmaceuticals Stock a Buy?
- KalVista Pharmaceuticals share price is 10.45 while KALV 8-day exponential moving average is 10.99, which is a Sell signal.
- The stock price of KALV is 10.45 while KalVista Pharmaceuticals 20-day EMA is 11.26, which makes it a Sell.
- KalVista Pharmaceuticals 50-day exponential moving average is 11.54 while KALV share price is 10.45, making it a Sell technically.
- KALV stock price is 10.45 and KalVista Pharmaceuticals 200-day simple moving average is 11.78, creating a Sell signal.
Fundamental Analysis of KalVista Pharmaceuticals
Is KalVista Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.07 per share.
Technical Analysis of KalVista Pharmaceuticals
Should I short KalVista Pharmaceuticals stock?
- KALV Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting KalVista Pharmaceuticals is a Sell
- KalVista Pharmaceuticals Relative Strength Index (RSI) is 40.61, which suggest KalVista Pharmaceuticals is oversold
- The Bollinger Bands (25) for KalVista Pharmaceuticals is (10.91 - 12.13), which suggest KalVista Pharmaceuticals is a Sell
- The Bollinger Bands (100) for KalVista Pharmaceuticals is (10.9 - 13.5), which suggest KalVista Pharmaceuticals is a Sell
* KalVista Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.